Strides Pharma Science share news and announcements
NSE: STARBSE: 532531Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹998.40.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9,354 Cr580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 31 Jul 2026
- 15.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 13 Jul 2026
- 3.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.49%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Jul 2026
- 21.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Jul 2026
- 15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 Jul 2026
- 0.53
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,12,38541.2% delivered
Strides Pharma Science routine notices
174 filed, newest first. Page 2 of 4.
May 2024
6 May · Routine
6 May · Routine
Mar 2024
18 Mar · Routine
8 Mar · Routine
Feb 2024
20 Feb · Routine
20 Feb · Routine
Jan 2024
31 Jan · Routine
23 Jan · Routine
8 Jan · Routine
8 Jan · Routine
Dec 2023
29 Dec · Routine
26 Dec · Routine
19 Dec · Routine
Nov 2023
28 Nov · Routine
Oct 2023
31 Oct · Routine
31 Oct · Routine
25 Oct · Routine
Sep 2023
6 Sep · Routine
Aug 2023
29 Aug · Routine
22 Aug · Routine
5 Aug · Routine
3 Aug · Routine
3 Aug · Routine
Jul 2023
22 Jul · Routine
19 Jul · Routine
18 Jul · Routine
12 Jul · Routine
Jun 2023
29 Jun · Routine
28 Jun · Routine
27 Jun · Routine
26 Jun · Routine
23 Jun · Routine
16 Jun · Routine
May 2023
26 May · Routine
24 May · Routine
19 May · Routine
Apr 2023
24 Apr · Routine
17 Apr · Routine
Mar 2023
20 Mar · Routine
Feb 2023
21 Feb · Routine
16 Feb · Routine
Jan 2023
25 Jan · Routine
14 Jan · Routine
Dec 2022
23 Dec · Routine
Nov 2022
15 Nov · Routine